For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Janssen Biopharma, Inc.

USPTO Granted Patents = 20

CIPO Patents = 20

EPO Patents = 7

Forward Citations = 43

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Leonid Beigelman (19 out of 224 patents)

Guangyi Wang (10 out of 55 patents)

David Bernard Smith (9 out of 88 patents)

4. Sergei M Gryaznov (5 out of 83 patents)

5. Vivek Kumar Rajwanshi (5 out of 18 patents)

6. Antitsa Dimitrova Stoycheva (4 out of 19 patents)

7. Jerome Deval (4 out of 28 patents)

8. Jin Hong (4 out of 10 patents)

9. Marija Prhavc (4 out of 19 patents)

10. Robert Than Hendricks (3 out of 18 patents)

11. Haiying He (2 out of 53 patents)

12. Carmela Napolitano (2 out of 5 patents)

13. Daniele Andreotti (2 out of 17 patents)

14. Natalia Dyatkina (2 out of 23 patents)

15. Anh P Truong (2 out of 15 patents)

20 patents: Sort by Forward Citations

1. 12428441 - Modified nucleoside phosphoramidites (2025-09-30),

2. 12030907 - Modified nucleoside phosphoramidites (2024-07-09),

3. 11312727 - Macrocyclic flu endonuclease inhibitors (2022-04-26),

4. 11180524 - Modified nucleoside phosphoramidites (2021-11-23),

5. 11149049 - Substituted nucleosides, nucleotides and analogs thereof (2021-10-19),

6. 11021509 - Substituted nucleosides, nucleotides and analogs thereof (2021-06-01),

7. 11021444 - Antiviral compounds (2021-06-01),

8. 11014935 - Compounds for the treatment of paramyxovirus viral infections (2021-05-25),

9. 10980805 - Aza-pyridone compounds and uses thereof (2021-04-20),

10. 10905767 - Oligonucleotide constructs and uses thereof (2021-02-02),

11. 10793859 - Modified oligonucleotides and methods of use (2020-10-06),

12. 10793591 - Substituted nucleosides, nucleotides and analogs thereof (2020-10-06),

13. 10780105 - Substituted nucleosides, nucleotides and analogs thereof (2020-09-22),

14. RE48171 - Substituted nucleosides, nucleotides and analogs thereof (2020-08-24),

15. 10745427 - Acyclic antivirals (2020-08-18),

Janssen BioPharma, Inc. is a leading pharmaceutical company specializing in innovative medicines, research, and development. With a commitment to improving the health and well-being of individuals worldwide, Janssen focuses on transforming individual lives through medical advancements. Visit their website to learn more about their diverse portfolio of products and ongoing efforts in healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

20 Patents

#61 in South San Francisco, CA

#3,801 in California

#15,856 in US

#30,316 in the World

South San Francisco, CA, United States of America

Janssen Biopharma, Inc.

Forward Citations = 43

65 inventors:

Leonid Beigelman (19 out of 224 patents)

Guangyi Wang (10 out of 55 patents)

David Bernard Smith (9 out of 88 patents)

4. Sergei M Gryaznov (5 out of 83 patents)

5. Vivek Kumar Rajwanshi (5 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…